IST 622

Drug Profile

IST 622

Alternative Names: A 132; A 132M; NSC 639830

Latest Information Update: 28 Nov 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ishihara Sangyo Kaisha
  • Class Cytostatic antibiotics
  • Mechanism of Action DNA topoisomerase inhibitors; RNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 28 Nov 2000 No-Development-Reported for Cancer in Japan (PO)
  • 17 Jul 1998 Profile reviewed
  • 28 Oct 1994 A study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top